| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.71M | - | |
| Other | 21.6K | $1.34M | - | |
| Other | 15.4K | $957.6K | -5,538 | |
| Dir | 8.0K | $496.2K | - | |
| Dir | 8.0K | $496.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2015 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 33,333 | $10.89 | $362,996.37 | -87.5% | |
| Aug 13, 2015 | Robin Howard W58 | President &CEO | Sale+OE | 58,333 | $10.89 | $635,246.37 | -85.4% | |
| Aug 12, 2015 | Nicholson John | SVP &Chief Financial Officer | Sale+OE | 319,884 | $10.78 | $3,449,413.56 | -67.9% | |
| Jul 14, 2015 | Labrucherie Gil M84 | SVP &General Counsel | Sale+OE | 33,334 | $11.78 | $392,674.52 | -88.7% | |
| Jul 14, 2015 | Robin Howard W58 | President &CEO | Sale+OE | 58,334 | $11.78 | $687,174.52 | -85.4% | |
| Jun 29, 2015 | Wang Susan | Director | Sale+OE | 30,000 | $12.70 | $381,000.00 | -42.9% | |
| Jun 19, 2015 | Chess Robert84 | Director | Sale+OE | 15,000 | $11.81 | $177,150.00 | -5.4% | |
| Jun 15, 2015 | Lingnau Lutz | Director | Sale+OE | 25,000 | $11.15 | $278,750.00 | -60.3% | |
| Jan 13, 2015 | Kuebler Christopher A58 | Director | Sale+OE | 15,000 | $16.00 | $240,000.00 | -42.9% |